CI

At a glance

ClinicalIndex Comparison Record
Phase 3Unknown· 600 enrolled
Drug / intervention
Vitamin B12dietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02272842
NCT02272842Phase 3Unknown

The Effect of Vitamin B12 Supplementation in Nepali Infants on Growth and Development

Centre For International Health·interventional·Posted Oct 23, 2014·Updated Sep 18, 2023

In Brief

A Phase 3 clinical trial evaluating Vitamin B12 for Development and 2 related conditions. Targeting 600 participants across 1 site.

Detailed Summary

Rationale: Globally, vitamin B12 deficiency is one of the most common micronutrient deficiencies. The only relevant source of Vitamin B12 is animal-source foods. Vitamin B12 is crucial for normal cell division and is necessary for brain growth as well as for the maintenance of its normal function. Deficiency is also associated with impaired growth. In a previous study, we demonstrated that vitamin B12 administration over a period of six months enhanced growth, and scores on a neuro-developmental test in young Indian children. However, the overall effect was small and, for the developmental scores significant only in those that were malnourished at the start of the study. Our findings need to be verified in trials targeting younger, malnourished children and with longer supplementation time. Hypothesis: This proposed study will test three hypotheses; to measure to what extent 2 recommended daily allowances (RDA) of vitamin B12 administration for one year to stunted children improves; 1) growth, 2) neurodevelopment, and 3) hemoglobin concentration. Study design: Randomized placebo-controlled trial. Half of the children will receive a paste containing vitamin B12, the other half the same paste but without vitamin B12. Study participants and site: 600 malnourished infants in Bhaktapur municipality in Nepal. In this population we have demonstrated that vitamin B12 deficiency and poor growth is common in early childhood. Intervention: Daily administration of a paste containing vitamin B12 or placebo for 12 months Data: The main outcomes of this study are scores on developmental assessments tools and growth measured every month for 12 months.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesNepal

Timeline

Phase 3UnknownOverdue
201520162017201820192020202120222023202420252026
First PostedOct 23, 2014
Enrollment StartApr 20, 2015
Primary CompletionFeb 28, 2018
Study CompletionDec 28, 2024
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 11.7 years ago

Interventions

Vitamin B12dietary

Vitamin B12 in a multivitamin paste.